Asciminib in HER2+ Breast Cancer Brain Metastases
NCT07136428
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
42
Enrollment
OTHER
Sponsor class
Conditions
HER2+ Metastatic Breast Cancer
Interventions
COMBINATION_PRODUCT:
Asciminib and Trastuzumab
Sponsor
Duke University
Collaborators
[object Object]